Gengfu Xiao to Pneumonia, Viral
This is a "connection" page, showing publications Gengfu Xiao has written about Pneumonia, Viral.
Connection Strength
0.091
-
Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro. Antiviral Res. 2020 10; 182:104868.
Score: 0.028
-
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 03; 30(3):269-271.
Score: 0.027
-
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein Cell. 2020 10; 11(10):723-739.
Score: 0.007
-
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol Sin. 2020 Sep; 41(9):1167-1177.
Score: 0.007
-
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020; 9(1):386-389.
Score: 0.007
-
A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 03; 579(7798):270-273.
Score: 0.007
-
Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein. Signal Transduct Target Ther. 2020 10 06; 5(1):220.
Score: 0.002
-
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur. Nat Struct Mol Biol. 2020 06; 27(6):529-532.
Score: 0.002
-
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science. 2020 06 19; 368(6497):1331-1335.
Score: 0.002
-
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020 06; 582(7811):289-293.
Score: 0.002